Vaccinogen's Series A - II Round

Vaccinogen raised a round of funding on February 12, 2010.

Vaccinogen is a cancer vaccine company developing OncoVAX as a treatment to prevent the recurrence of colon cancer and potentially other solid tumors. Vaccinogen has developed and patented a process t…

Articles about Vaccinogen's Series A - II Round: